Eur Rev Med Pharmacol Sci 2008; 12 (5): 139-140

New therapeutic approaches in irritable bowel syndrome

M. Camilleri

Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) Program, Mayo Clinic, Rochester, MN (USA) Corresponding Author: Michael Camilleri, MD; e-mail: camilleri.michael@mayo.edu

Free PDF Download

To cite this article

M. Camilleri
New therapeutic approaches in irritable bowel syndrome

Eur Rev Med Pharmacol Sci
Year: 2008
Vol. 12 - N. 5
Pages: 139-140

Keywords Related articles:

  1. Focus on irritable bowel syndrome
  2. Small intestine bacterial overgrowth in patients with irritable bowel syndrome
  3. The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide
  4. Octatropine methyl bromide and diazepam combination (Valpinax®) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial
  5. New therapeutic approach in inflammatory bowel disease